Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Esomeprazole in these regions, from 2012 to 2022 (forecast).
United States Esomeprazole market competition by top manufacturers/players, with Esomeprazole sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AstraZeneca AB
Sandoz
Actavis
Teva
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Capsule
Tablet
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Esomeprazole for each application, including
Children
Adult
Old
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Esomeprazole Market Report 2017
1 Esomeprazole Overview
1.1 Product Overview and Scope of Esomeprazole
1.2 Classification of Esomeprazole by Product Category
1.2.1 United States Esomeprazole Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Esomeprazole Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Other
1.3 United States Esomeprazole Market by Application/End Users
1.3.1 United States Esomeprazole Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Children
1.3.3 Adult
1.3.4 Old
1.4 United States Esomeprazole Market by Region
1.4.1 United States Esomeprazole Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Esomeprazole Status and Prospect (2012-2022)
1.4.3 Southwest Esomeprazole Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Esomeprazole Status and Prospect (2012-2022)
1.4.5 New England Esomeprazole Status and Prospect (2012-2022)
1.4.6 The South Esomeprazole Status and Prospect (2012-2022)
1.4.7 The Midwest Esomeprazole Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Esomeprazole (2012-2022)
1.5.1 United States Esomeprazole Sales and Growth Rate (2012-2022)
1.5.2 United States Esomeprazole Revenue and Growth Rate (2012-2022)
2 United States Esomeprazole Market Competition by Players/Suppliers
2.1 United States Esomeprazole Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Esomeprazole Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Esomeprazole Average Price by Players/Suppliers (2012-2017)
2.4 United States Esomeprazole Market Competitive Situation and Trends
2.4.1 United States Esomeprazole Market Concentration Rate
2.4.2 United States Esomeprazole Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Esomeprazole Manufacturing Base Distribution, Sales Area, Product Type
3 United States Esomeprazole Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Esomeprazole Sales and Market Share by Region (2012-2017)
3.2 United States Esomeprazole Revenue and Market Share by Region (2012-2017)
3.3 United States Esomeprazole Price by Region (2012-2017)
4 United States Esomeprazole Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Esomeprazole Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Esomeprazole Revenue and Market Share by Type (2012-2017)
4.3 United States Esomeprazole Price by Type (2012-2017)
4.4 United States Esomeprazole Sales Growth Rate by Type (2012-2017)
5 United States Esomeprazole Sales (Volume) by Application (2012-2017)
5.1 United States Esomeprazole Sales and Market Share by Application (2012-2017)
5.2 United States Esomeprazole Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Esomeprazole Players/Suppliers Profiles and Sales Data
6.1 AstraZeneca AB
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Esomeprazole Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AstraZeneca AB Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sandoz
6.2.2 Esomeprazole Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sandoz Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Actavis
6.3.2 Esomeprazole Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Actavis Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Teva
6.4.2 Esomeprazole Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Teva Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.2 Esomeprazole Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 KernPharm
6.6.2 Esomeprazole Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 KernPharm Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Garmish Pharmaceuticals
6.7.2 Esomeprazole Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Garmish Pharmaceuticals Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.2 Esomeprazole Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Mepha
6.9.2 Esomeprazole Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Mepha Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Saval Pharmaceutical
6.10.2 Esomeprazole Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Saval Pharmaceutical Esomeprazole Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Stada
6.12 Blaskov
6.13 CQ Lummy
7 Esomeprazole Manufacturing Cost Analysis
7.1 Esomeprazole Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Esomeprazole
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Esomeprazole Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Esomeprazole Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Esomeprazole Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Esomeprazole Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Esomeprazole Sales Volume Forecast by Type (2017-2022)
11.3 United States Esomeprazole Sales Volume Forecast by Application (2017-2022)
11.4 United States Esomeprazole Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Esomeprazole
Figure United States Esomeprazole Market Size (MT) by Type (2012-2022)
Figure United States Esomeprazole Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure Other Product Picture
Figure United States Esomeprazole Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Esomeprazole by Application in 2016
Figure Children Examples
Figure Adult Examples
Figure Old Examples
Figure United States Esomeprazole Market Size (Million USD) by Region (2012-2022)
Figure The West Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Esomeprazole Sales (MT) and Growth Rate (2012-2022)
Figure United States Esomeprazole Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Esomeprazole Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Esomeprazole Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Esomeprazole Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Esomeprazole Sales Share by Players/Suppliers
Figure 2017 United States Esomeprazole Sales Share by Players/Suppliers
Figure United States Esomeprazole Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Esomeprazole Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Esomeprazole Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Esomeprazole Revenue Share by Players/Suppliers
Figure 2017 United States Esomeprazole Revenue Share by Players/Suppliers
Table United States Market Esomeprazole Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Esomeprazole Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Esomeprazole Market Share of Top 3 Players/Suppliers
Figure United States Esomeprazole Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Esomeprazole Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Esomeprazole Product Category
Table United States Esomeprazole Sales (MT) by Region (2012-2017)
Table United States Esomeprazole Sales Share by Region (2012-2017)
Figure United States Esomeprazole Sales Share by Region (2012-2017)
Figure United States Esomeprazole Sales Market Share by Region in 2016
Table United States Esomeprazole Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Esomeprazole Revenue Share by Region (2012-2017)
Figure United States Esomeprazole Revenue Market Share by Region (2012-2017)
Figure United States Esomeprazole Revenue Market Share by Region in 2016
Table United States Esomeprazole Price (USD/MT) by Region (2012-2017)
Table United States Esomeprazole Sales (MT) by Type (2012-2017)
Table United States Esomeprazole Sales Share by Type (2012-2017)
Figure United States Esomeprazole Sales Share by Type (2012-2017)
Figure United States Esomeprazole Sales Market Share by Type in 2016
Table United States Esomeprazole Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Esomeprazole Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Esomeprazole by Type (2012-2017)
Figure Revenue Market Share of Esomeprazole by Type in 2016
Table United States Esomeprazole Price (USD/MT) by Types (2012-2017)
Figure United States Esomeprazole Sales Growth Rate by Type (2012-2017)
Table United States Esomeprazole Sales (MT) by Application (2012-2017)
Table United States Esomeprazole Sales Market Share by Application (2012-2017)
Figure United States Esomeprazole Sales Market Share by Application (2012-2017)
Figure United States Esomeprazole Sales Market Share by Application in 2016
Table United States Esomeprazole Sales Growth Rate by Application (2012-2017)
Figure United States Esomeprazole Sales Growth Rate by Application (2012-2017)
Table AstraZeneca AB Basic Information List
Table AstraZeneca AB Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca AB Esomeprazole Sales Growth Rate (2012-2017)
Figure AstraZeneca AB Esomeprazole Sales Market Share in United States (2012-2017)
Figure AstraZeneca AB Esomeprazole Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz Esomeprazole Sales Growth Rate (2012-2017)
Figure Sandoz Esomeprazole Sales Market Share in United States (2012-2017)
Figure Sandoz Esomeprazole Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Actavis Esomeprazole Sales Growth Rate (2012-2017)
Figure Actavis Esomeprazole Sales Market Share in United States (2012-2017)
Figure Actavis Esomeprazole Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Esomeprazole Sales Growth Rate (2012-2017)
Figure Teva Esomeprazole Sales Market Share in United States (2012-2017)
Figure Teva Esomeprazole Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Esomeprazole Sales Growth Rate (2012-2017)
Figure Mylan Esomeprazole Sales Market Share in United States (2012-2017)
Figure Mylan Esomeprazole Revenue Market Share in United States (2012-2017)
Table KernPharm Basic Information List
Table KernPharm Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure KernPharm Esomeprazole Sales Growth Rate (2012-2017)
Figure KernPharm Esomeprazole Sales Market Share in United States (2012-2017)
Figure KernPharm Esomeprazole Revenue Market Share in United States (2012-2017)
Table Garmish Pharmaceuticals Basic Information List
Table Garmish Pharmaceuticals Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Garmish Pharmaceuticals Esomeprazole Sales Growth Rate (2012-2017)
Figure Garmish Pharmaceuticals Esomeprazole Sales Market Share in United States (2012-2017)
Figure Garmish Pharmaceuticals Esomeprazole Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Esomeprazole Sales Growth Rate (2012-2017)
Figure Sanofi Esomeprazole Sales Market Share in United States (2012-2017)
Figure Sanofi Esomeprazole Revenue Market Share in United States (2012-2017)
Table Mepha Basic Information List
Table Mepha Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mepha Esomeprazole Sales Growth Rate (2012-2017)
Figure Mepha Esomeprazole Sales Market Share in United States (2012-2017)
Figure Mepha Esomeprazole Revenue Market Share in United States (2012-2017)
Table Saval Pharmaceutical Basic Information List
Table Saval Pharmaceutical Esomeprazole Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Saval Pharmaceutical Esomeprazole Sales Growth Rate (2012-2017)
Figure Saval Pharmaceutical Esomeprazole Sales Market Share in United States (2012-2017)
Figure Saval Pharmaceutical Esomeprazole Revenue Market Share in United States (2012-2017)
Table Stada Basic Information List
Table Blaskov Basic Information List
Table CQ Lummy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Esomeprazole
Figure Manufacturing Process Analysis of Esomeprazole
Figure Esomeprazole Industrial Chain Analysis
Table Raw Materials Sources of Esomeprazole Major Players/Suppliers in 2016
Table Major Buyers of Esomeprazole
Table Distributors/Traders List
Figure United States Esomeprazole Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Esomeprazole Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Esomeprazole Price (USD/MT) Trend Forecast (2017-2022)
Table United States Esomeprazole Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Esomeprazole Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Esomeprazole Sales Volume (MT) Forecast by Type in 2022
Table United States Esomeprazole Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Esomeprazole Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Esomeprazole Sales Volume (MT) Forecast by Application in 2022
Table United States Esomeprazole Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Esomeprazole Sales Volume Share Forecast by Region (2017-2022)
Figure United States Esomeprazole Sales Volume Share Forecast by Region (2017-2022)
Figure United States Esomeprazole Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...